Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian C Hayday

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Annals of the New York Academy of Sciences|November 16, 2022
Antibodies as drugs-a Keystone Symposia reportJennifer Cable, Erica Ollmann Saphire, Adrian C Hayday, et al.
Nature Communications|June 8, 2021
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive careClemens Gutmann, Kaloyan Takov, Sean A Burnap, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2022
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19Magdalene Joseph, Yin Wu, Richard Dannebaum, et al.
The Lancet. Oncology|April 30, 2021
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational studyLeticia Monin, Adam G Laing, Miguel Muñoz-Ruiz, et al.
Nature Medicine|September 10, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Medicine|November 28, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Cancer Cell|January 21, 2021
Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer PatientsSultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai, et al.
Nature Medicine|August 19, 2020
A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Immunology|December 18, 2019
High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variationLucie Abeler-Dörner, Adam G Laing, Anna Lorenc, et al.
The Journal of Experimental Medicine|November 22, 2024
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)Evangelos Bellos, Dilys Santillo, Pierre Vantourout, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Annals of the New York Academy of Sciences|November 16, 2022
Antibodies as drugs-a Keystone Symposia reportJennifer Cable, Erica Ollmann Saphire, Adrian C Hayday, et al.
Nature Communications|June 8, 2021
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive careClemens Gutmann, Kaloyan Takov, Sean A Burnap, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2022
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19Magdalene Joseph, Yin Wu, Richard Dannebaum, et al.
The Lancet. Oncology|April 30, 2021
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational studyLeticia Monin, Adam G Laing, Miguel Muñoz-Ruiz, et al.
Nature Medicine|September 10, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Medicine|November 28, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Cancer Cell|January 21, 2021
Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer PatientsSultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai, et al.
Nature Medicine|August 19, 2020
A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Immunology|December 18, 2019
High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variationLucie Abeler-Dörner, Adam G Laing, Anna Lorenc, et al.
The Journal of Experimental Medicine|November 22, 2024
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)Evangelos Bellos, Dilys Santillo, Pierre Vantourout, et al.
Pageof 11